CLINICAL OBSERVATION OF TRIPLE THERAPY REGIMEN WITHLANSOPRAZOLE, CLARITHROMYCIN AND METRONIDAZOLE FOR TREATMENT OF HELICOBACTER PYLORI-RELATED ULCER
10.3969/j.issn.1671-332X.2009.07.005
- VernacularTitle:兰索拉唑、克拉霉素、甲硝唑三联疗法治疗幽门螺杆菌相关性溃疡病疗效观察
- Author:
Ju JIANG
- Publication Type:Journal Article
- Keywords:
Digestive ulcer;
Helicobactor pylori
- From:
Modern Hospital
2009;9(7):13-14
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate therapeutic effects of triple therapy combined Lansoprazole, clarithromycin and metronidazole for eradicating Helicobacter pylori-related ulcer. Methods Fivty-one patients with H. pylori-infected stomach ulcer or duodenal ulcer received the treatment of triple therapy regimen with lansoprazole, clarithromycin and metronidazole.the efficacy of ulcer healing and hp eradication were observed. Results the cure rate of the triple therapy was 90%,and the eradication rate of H. pylori was 88%.Conclusions Triple therapy using combined Lansoprazole, clarithromycin and metronidazole is worthy of clinical application for curing pylori - infected peptic ulcer accompanied by the lower does, the higher hp eradication rate, ulcer healing more rapidly and the shorter course of treatment.
